Your browser doesn't support javascript.
loading
ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis.
Burkbauer, Laura; Goldbach, Macy M; Tchou, Julia C.
Afiliação
  • Burkbauer L; Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 10th Floor PCAM South, Philadelphia, PA, 19104, USA.
  • Goldbach MM; Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 10th Floor PCAM South, Philadelphia, PA, 19104, USA.
  • Tchou JC; Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 10th Floor PCAM South, Philadelphia, PA, 19104, USA. Julia.Tchou@pennmedicine.upenn.edu.
Ann Surg Oncol ; 28(13): 8663-8664, 2021 12.
Article em En | MEDLINE | ID: mdl-34304315
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante Idioma: En Ano de publicação: 2021 Tipo de documento: Article